Osteoporosis and bone transfer for breast cancer patients

1. Osteoporosis does not imply bone transfer.

Osteoporosis is often accompanied by bone transfer, which is characterized by fractures in the form of an increase in the number of broken bone cells and the release of inflammatory factors. In the case of bone transfer, which is dominated by fractured bone cells, there is often an increase in single nucleus cells in the blood, and these increases in nucleus and inflammatory factors lead to osteoporosis and further exacerbate osteoporosis. But this does not mean that osteoporosis must be a bone transfer signal. As the causes of osteoporosis are more numerous, bone transfer is only one of them. Age growth, decreased estrogen levels, effects of tumour treatment, etc. can cause osteoporosis. However, osteoporosis does not occur too lightly because, as a result of osteoporosis, changes in the skeletal environment may have an impact on the transfer of breast cancer bones and contribute to their occurrence. Therefore, if osteoporosis is detected, it is recommended that prevention and treatment be carried out ahead of time, as not only the fear of bone transfer but, more importantly, the quality of daily life is affected.

What about the bone transfer of breast cancer? What tests are required?

If a breast cancer patient suffers from a disorder such as bone pain, or if there is an increase in calcium, alkaline phosphate, lactate dehydrogenase, or an abnormal increase in tumor markers, a OCRA scan should be performed in a timely manner and if abnormality is detected, an X-line, CT, or MRI examination may be performed on specific areas, and if necessary, a bone biopsy should be performed to ascertain whether there is a bone transfer. If a bone transfer is detected, treatment should be provided as soon as possible, including surgical treatment, medication and local treatment. The purpose of surgical treatment is primarily to alleviate neuropressure and pain. Drug treatment, including chemotherapy, endocrine treatment, molecular targeting, immunotherapy, bone improvement drugs, etc. In any case, in case of bone transfer symptoms of breast cancer, the patient should be treated and examined in a timely manner so that the doctor can develop appropriate treatment programmes and control the development of the condition. At the same time, patients should actively cooperate with treatment and maintain a good mindset and living habits to meet this challenge.